Vulnerabilities

Vulnerability · CVE-2025-15632

A vulnerability has been found in 1Panel-dev MaxKB up to 2.4.2.

Published Apr 13, 2026 · catalog updated Oct 7, 2026 · A vulnerability has been

Check if you run it

No confirmed exploitation is on record for CVE-2025-15632. EPSS is 0.27%. Act only if a listed version of A vulnerability has been is installed.

Gaps on this record

  • The stored product name is a package slug. The name on this page is taken from the title (A vulnerability has been).
  • No version range is stored. A customer cannot check an installed version against this record.
  • No vendor fix or required action is stored. Compare the linked advisory before you change production.
Severity
Low2.0
Known exploitation
Not in CISA/VulnCheck KEV
EPSS
0.27%
Remediation
Not established
Affected products
See sources for product scope

A vulnerability has been found in 1Panel-dev MaxKB up to 2.4.2. Impacted is an unknown function of the file ui/src/chat.ts of the component MdPreview. Such manipulation leads to cross site scripting. The attack can be executed remotely. The exploit has been disclosed to the public and may be used. Upgrading to version 2.5.0 is recommended to address this issue. The name of the patch is 7230daa5ec3e6574b6ede83dd48a4fbc0e70b8d8. It is advisable to upgrade the affected component. The vendor was contacted early, responded in a very professional manner and quickly released a fixed version of the affected product.

No affected version ranges are stored yet. Use the vendor advisory before you decide this record does not apply.

How to fix CVE-2025-15632

What to do

Three questions, each answered from this record only. Confirm the vendor advisory before you patch.

Should you patch?

No confirmed exploitation is on record for CVE-2025-15632. EPSS is 0.27%. Act only if a listed version of A vulnerability has been is installed.

Which versions are affected?

Affected version ranges are not on this record. Compare the installed version with the linked vendor advisory before you change production.

What should an analyst verify?

CWE-79: Cross-site Scripting (XSS); CWE-94: Code Injection. EPSS 0.27%. There is no CISA KEV listing. No Exploit-DB or Metasploit reference is linked. Use the source links for the original advisory.

Code

The project this record applies to. Exploit listings stay in References.

Timeline

Detection, updates, and resolution for this record.

  1. Apr 13, 2026 · NIST NVD

    Detected

    A vulnerability has been found in 1Panel-dev MaxKB up to 2.4.2. Impacted is an unknown function of the file ui/src/chat.ts of the component MdPreview. Such manipulation leads to cross site scripting. The attack can be executed remotely. The exploit has been disclosed to the public and may be used. Upgrading to version 2.5.0 is recommended to address this issue. The name of the patch is 7230daa5ec3

  2. Oct 7, 2026 · NIST NVD

    Updated

    A vulnerability has been found in 1Panel-dev MaxKB up to 2.4.2. Impacted is an unknown function of the file ui/src/chat.ts of the component MdPreview. Such manipulation leads to cross site scripting. The attack can be executed remotely. The exploit has been disclosed to the public and may be used. Upgrading to version 2.5.0 is recommended to address this issue. The name of the patch is 7230daa5ec3

Sources

  • CVE.orgVulnerability recordCVE-2025-15632

    Official CVE identifier

    cve.org
  • FIRST EPSSExploitation probabilityCVE-2025-15632

    30-day exploitation probability 0.3%

    first.org
  • NIST NVDVulnerability recordCVE-2025-15632

    A vulnerability has been found in 1Panel-dev MaxKB up to 2.4.2. Impacted is an unknown function of the file ui/src/chat.ts of the component MdPreview. Such manipulation leads to cross site scripting. The attack can be executed remotely. The exploit has been disclosed to the publi

    nvd.nist.gov

References

Freshness

Last verified in this catalog Oct 16, 2026. Significant claims (KEV, EPSS, CVSS, affected ranges) come from the source rows above — open the original publisher for the authoritative advisory.